摘要
药物性高血压是指在临床工作中,使用常规药物剂量治病时,由于药物本身作用或该药物与其他药物之间发生相互作用而引起血压升高,当血压超过140/90mmHg(1mmHg=0.133kPa)时即考虑药物性高血压。在高血压病因分类中,药物性高血压属于继发性高血压。
出处
《中华全科医师杂志》
2007年第9期542-544,共3页
Chinese Journal of General Practitioners
参考文献7
-
1刘杰.雄激素替代疗法的现在和将来[J].国外医学(药学分册),2005,32(4):259-261. 被引量:4
-
2童南伟,冉兴无,李启富,汤保德,李蓉,杨凤英,刘玉平,李秀钧.西布曲明对肥胖患者糖脂代谢、体脂及胰岛素抵抗影响的多中心研究[J].中华内科杂志,2005,44(9):659-663. 被引量:4
-
3胡大一.关于Cox-2抑制剂Celebrex心血管安全性的新进展[J].中国循证医学杂志,2005,5(1):6-7. 被引量:2
-
4纪立农.噻唑烷二酮类药物与心脏的安全性[J].中国糖尿病杂志,2004,12(1):65-66. 被引量:5
-
5傅海霞,关广聚.促红细胞生成素诱发高血压机制研究进展[J].山东医药,2003,43(22):63-63. 被引量:7
-
6陈广祥,陈丽.脂肪组织内分泌功能与胰岛素抵抗[J].临床军医杂志,2003,31(1):96-98. 被引量:14
-
7吕向华.麻黄素相关药物的应用现状[J].山西医药杂志,2002,31(5):363-365. 被引量:3
二级参考文献33
-
1黄志龙,郝石生.盖层突破压力及排替压力的求取方法[J].新疆石油地质,1994,15(2):163-166. 被引量:36
-
2程大敦.右旋伪麻黄碱应充分利用[J].药学通报,1986,21(6):365-367.
-
3Nesto RW, et al. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Circulation, 2003,108: 2941-2948.
-
4Kuriyana S, Tomonari H,Tokudome G, et al. Association of angiotensingen gene polymorphism with erythropoientin-induced hypertension : a preliminary report. Hypertens Res, 2001,24 (5) :50-55.
-
5Vaziri ND, Tamai O, Kohno K, et al. Cardiovascular effects of erythropoietin and anemia correction. Curr Opin Nephrol Hyoertens, 2001,10(5) : 633-637.
-
6Ni Z, Wang XQ, Vaziri ND. Nitric Oxide metabolism in erythropoietin-induced hypertension:effect of calcium channel blockade. Hypertension, 1998,32(4):724 - 729.
-
7Execuitive Summary of Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel Ⅲ). JAMA, 2001, 285: 2486-2497.
-
8Bergstrom RW, Newell-Morris LL, Leonetti DL, et al. Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese- American men. Diabetes, 1990, 39: 104-111.
-
9Colditz GA, Willett WC, Rotnitzky A, et al. Weight gain as a risk factor for clinical diabetes in women. Ann Intern Med, 1995, 122: 481-486.
-
10Ferland M, Despres JP, Tremblay A, et al. Assessment of adipose tissue distribution by computed axial tomography in obese women: assocation with body density and anthropometric measurements. Br J Nutr, 1989, 61: 139-148.
共引文献32
-
1金成,赵瑛,张颖,罗兰,殷惠军.胰岛素抵抗与糖脂代谢[J].中西医结合心脑血管病杂志,2004,2(9):537-540. 被引量:3
-
2和振坤.肝动脉栓塞化疗患者甘草甜素的保肝作用[J].第四军医大学学报,2004,25(18):1677-1678. 被引量:1
-
3赵红艺,李斌.去脂术—肥胖—2型糖尿病关系探讨[J].中国现代医药杂志,2004,6(6):68-70.
-
4刘蕴玲,岳峰,刘佳.2型糖尿病患者血清瘦素水平与胰岛素抵抗的相关性研究[J].山东医药,2005,45(11):47-48. 被引量:2
-
5赵文霞,张玉禄.消脂护肝胶囊对非酒精性脂肪肝患者胰岛素抵抗及瘦素水平的影响[J].中医研究,2005,18(5):21-23. 被引量:12
-
6李卉,刘振华,李彦.马来酸罗格列酮的不良反应[J].药物不良反应杂志,2005,7(3):185-188. 被引量:5
-
7甘华侠,朱凌燕,徐积兄,陈惠贤.文迪雅治疗2型糖尿病的疗效观察[J].江西医学院学报,2005,45(4):96-97.
-
8魏玲,杨丽霞,赵颖,王先梅,郭传明,齐峰,任丽,李丽俐.血红蛋白含量与高血压靶器官损伤[J].高血压杂志,2006,14(5):360-363. 被引量:12
-
9赵建林,童南伟.肥胖与慢性炎症[J].实用糖尿病杂志,2006,2(6):11-13. 被引量:5
-
10王兵,朱平生.舒肝活血化痰方对非酒精性脂肪性肝炎大鼠血清瘦素、胰岛素抵抗指数的影响[J].中国中医药信息杂志,2007,14(2):39-41. 被引量:4
同被引文献23
-
1石奕武,廖卫平.抗癫痫药物引起的Stevens-Johnson综合症与HLA-B*1502[J].重庆医科大学学报,2008,33(z1):94-95. 被引量:5
-
2郭艺芳,胡大一.血压的晨峰现象及其临床意义[J].中华全科医师杂志,2007,6(9):521-523. 被引量:17
-
3Aronow WS, Fleg JL, Pepine CJ, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly : a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Coil Cardiol, 2011, 57: 2037-2114.
-
4Muller JE, Stone PH, Turi ZG, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med , 1985,313 : 1315-1322.
-
5Marler JR, Price TR, Clark GL, et al. Morning increase in onset of ischemic stroke. Stroke, 1989,20:473-476.
-
6Zhu N, Bu M, Chen D, et al. A study of white-coat phenomenon in patients with primary hypertension. Hypertens Res, 2008,31 : 37-41.
-
7Aronow WS. Why and how we should treat elderly patients with hypertension? Curt Vasc Pharmacol, 2010,8:780-787.
-
8Rastas S, Pirttila T, Viramo P, et al. Association between blood pressure and survival over 9 years in a general population aged $5 and older. J Am Geriatr Soc ,2006,54:912-918.
-
9Saito I, Suzuki H, Kageyama S, et al. Treatment of hypertension in patients 85 years of age or older: a J-BRAVE substudy. Clin Exp Hypertens, 2011,33:275-280.
-
10Oates DJ, Berlowitz DR, Glickman ME, et al. Blood pressure and survival in the oldest old. J Am Geriatr Soe, 2007,55:383-388.
二级引证文献3
-
1高艳,马悦,何琴.卡马西平致大疱表皮松解坏死型药疹1例及文献复习[J].医药导报,2017,36(A01):146-147. 被引量:1
-
2魏天龙,刘金伟,李璐璐,张耕.卡马西平致超敏反应综合征死亡1例[J].医药导报,2017,36(11):1328-1329. 被引量:2
-
3周杰,李娇,杨荣杰,郭芸.重症药疹的治疗进展[J].中国麻风皮肤病杂志,2020,36(9):566-570. 被引量:10
-
1李本辉.奥美拉唑与泮托拉唑治疗消化性溃疡临床体会[J].中国处方药,2016,14(4):25-26. 被引量:4
-
2姚品方,张兆果.176例老年人上消化道出血的临床特点[J].实用老年医学,1991,5(4):171-171.
-
3沈志祥.上消化道出血的病因分类[J].中国实用内科杂志,1998,18(1):3-4. 被引量:46
-
4彭康.防治便秘有哪些饮食疗法[J].家庭医药(就医选药),2013(9):63-63.
-
5刘侃.联合用药治疗慢性充血性心力衰竭的临床研究[J].中外医疗,2011,30(28):106-106.
-
6阚准.麝香保心丸对急性冠脉综合征超敏C反应蛋白的影响[J].中国社区医师(医学专业),2010,12(8):141-142.
-
7何吟绵,方蕴春.老年慢性肺源性心脏病112例临床分析[J].实用老年医学,2001,15(6):335-336. 被引量:1
-
8杨映娟.蝮蛇抗栓酶治病糖尿病并发症31例[J].桂林医学杂志,1997,13(2):86-87.
-
9吴广利.干扰素治疗慢性丙型肝炎的影响因素[J].滨州医学院学报,1996,19(2):199-201.
-
10张诺春.消化性溃疡的病因分析与药物治疗[J].临床医药文献电子杂志,2014,1(18):2709-2710. 被引量:7